Common Stock, Shares, Outstanding of AXIM BIOTECHNOLOGIES, INC. from 31 Dec 2010 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AXIM BIOTECHNOLOGIES, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Jun 2024.
  • AXIM BIOTECHNOLOGIES, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 294,458,824, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 294,458,824 +66,809,421 +29% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 278,429,403 +54,780,000 +24% 31 Mar 2024 10-Q/A 22 May 2024 2024 Q1
Q4 2023 245,929,403 +53,487,486 +28% 31 Dec 2023 10-Q 19 Aug 2024 2024 Q2
Q3 2023 237,649,403 +99,549,422 +72% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 227,649,403 +89,549,422 +65% 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 223,649,403 +72,147,621 +48% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 192,441,917 +54,341,936 +39% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 138,099,981 +2,214,877 +1.6% 30 Sep 2022 10-Q/A 15 Nov 2022 2022 Q3
Q2 2022 138,099,981 +5,075,546 +3.8% 30 Jun 2022 10-Q 16 Aug 2022 2022 Q2
Q1 2022 151,501,782 +23,973,275 +19% 31 Mar 2022 10-Q 23 May 2022 2022 Q1
Q4 2021 138,099,981 +12,772,402 +10% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 135,885,104 +10,688,134 +8.5% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 133,024,435 +19,880,213 +18% 30 Jun 2021 10-Q 23 Aug 2021 2021 Q2
Q1 2021 127,528,507 +4,219,462 +3.4% 31 Mar 2021 10-Q/A 02 Jun 2021 2021 Q1
Q4 2020 125,327,579 +60,473,040 +93% 31 Dec 2020 10-K/A 19 Apr 2022 2021 FY
Q3 2020 125,196,970 +62,411,551 +99% 30 Sep 2020 10-Q/A 27 Nov 2020 2020 Q3
Q2 2020 113,144,222 +51,302,143 +83% 30 Jun 2020 10-Q/A 18 Aug 2020 2020 Q2
Q1 2020 123,309,045 +62,236,634 +102% 31 Mar 2020 10-Q/A 02 Jul 2020 2020 Q1
Q4 2019 64,854,539 +5,271,649 +8.8% 31 Dec 2019 10-K/A 26 Apr 2021 2020 FY
Q3 2019 62,785,419 +4,119,976 +7% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 61,842,079 +4,300,851 +7.5% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 61,072,411 +4,405,961 +7.8% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 59,582,890 +5,018,449 +9.2% 31 Dec 2018 10-K/A 20 May 2020 2019 FY
Q3 2018 58,665,443 +4,101,002 +7.5% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 57,541,228 +4,971,787 +9.5% 30 Jun 2018 10-Q/A 17 Aug 2018 2018 Q2
Q1 2018 56,666,450 +4,100,009 +7.8% 31 Mar 2018 10-Q/A 18 May 2018 2018 Q1
Q4 2017 54,564,441 +2,058,000 +3.9% 31 Dec 2017 10-K 08 Apr 2019 2018 FY
Q3 2017 54,564,441 +3,071,782 +6% 30 Sep 2017 10-Q 20 Nov 2017 2017 Q3
Q2 2017 52,569,441 +10,766,782 +26% 30 Jun 2017 10-Q/A 14 Sep 2017 2017 Q2
Q1 2017 52,566,441 +12,803,782 +32% 31 Mar 2017 10-Q/A 14 Sep 2017 2017 Q1
Q4 2016 52,506,441 +12,872,735 +32% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 51,492,659 +12,127,953 +31% 30 Sep 2016 10-Q/A 30 Nov 2016 2016 Q3
Q2 2016 41,802,659 +2,457,953 +6.2% 30 Jun 2016 10-Q/A 25 Aug 2016 2016 Q2
Q1 2016 39,762,659 +6,744,659 +20% 31 Mar 2016 10-Q/A 26 May 2016 2016 Q1
Q4 2015 39,633,706 +6,633,706 +20% 31 Dec 2015 10-K/A 14 Sep 2017 2016 FY
Q3 2015 39,364,706 +6,364,706 +19% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 39,344,706 +6,344,706 +19% 30 Jun 2015 10-Q/A 27 Aug 2015 2015 Q2
Q1 2015 33,018,000 +18,000 +0.06% 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 33,000,000 0 0% 31 Dec 2014 10-K/A 18 Apr 2016 2015 FY
Q3 2014 33,000,000 0 0% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 33,000,000 0 0% 30 Jun 2014 10-Q/A 26 Aug 2014 2014 Q2
Q1 2014 33,000,000 0 0% 31 Mar 2014 10-Q/A 18 Jun 2014 2014 Q1
Q4 2013 33,000,000 0 0% 31 Dec 2013 10-K 14 Apr 2015 2014 FY
Q3 2013 33,000,000 0 0% 30 Sep 2013 10-Q 18 Nov 2013 2013 Q3
Q2 2013 33,000,000 0 0% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 33,000,000 0 0% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 33,000,000 0 0% 31 Dec 2012 10-K 04 Mar 2014 2013 FY
Q3 2012 33,000,000 0 0% 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q2 2012 33,000,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 33,000,000 31 Mar 2012 10-Q 17 May 2012 2012 Q1
Q4 2011 33,000,000 +13,000,000 +65% 31 Dec 2011 10-K 15 Apr 2013 2012 FY
Q3 2011 33,000,000 30 Sep 2011 10-Q/A 21 Nov 2011 2011 Q3
Q4 2010 20,000,000 31 Dec 2010 10-K/A 01 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.